April 2018

Column

Counterpoint

Understanding Provider Perceptions Is Key to Utilization and Uptake of CAR-T Therapy

04/17/2018

The potential impact of chimeric antigen receptor T-cell (CAR-T) therapies should not be underestimated, nor should their complexity. There is much to consider when reprogramming patients’ own immune cells. As most...

The...

04/17/2018

Journal of Clinical Pathways

Viewpoint

The CAR-T Breakthrough: More Than Just Another Treatment Option

04/17/2018

Winston Wong , PharmD;

The ability to rewire human immune systems to fight cancer is certainly an exciting prospect. With the first 2 chimeric antigen receptor T-cell (CAR-T) therapies approved and over 200 more in clinical trials,...

The...

04/17/2018

Journal of Clinical Pathways

Clinical Pathways GPS

Dealing With New Formulary Types: Health System Outpatient Formularies

04/17/2018

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Developers and utilizers of clinical pathways need to understand that formulary systems encompass more than merely a list of medications approved by a managed care organization. These stakeholders should also factor...

...

04/17/2018

Journal of Clinical Pathways

Pharma Insights

Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling

04/17/2018

Philip L. Cyr , MPH;

Larry Blandford , PharmD;

Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...

...

04/17/2018

Journal of Clinical Pathways

Editor's Page

Working Together to Ensure Patient Access to Clinical Advancements

04/17/2018

Winston Wong , PharmD;

It is an exciting time in oncology care as innovative cellular and gene therapies come to market, with many more to come in the near future. While the promise of these therapies is certainly cause for enthusiasm,...

It is...

04/17/2018

Journal of Clinical Pathways

Feature

Perspectives

Creating Value in Cancer Care Through Standardized Metrics and Partnerships Between Patient Navigators and Physicians

04/17/2018

Tricia Strusowski , MS, RN;

Abstract: While providers and care systems can agree that effective patient navigation programs are essential to positive patient outcomes, there have been no standard metrics that could be used to measure the...

...

04/17/2018

Journal of Clinical Pathways

Insights

Interview

McKesson Specialty Health`s Oncology-Specific EHR: A Model for Advancing Value-Based Care

04/17/2018

JCP Editors

For the second consecutive year, McKesson Specialty Health has received approval from the Centers for Medicare & Medicaid Services (CMS) to participate in the Merit-Based Incentive Payment System (MIPS) program...

For...

04/17/2018

Journal of Clinical Pathways

National Comprehensive Cancer Network Annual Conference

04/17/2018

JCP Editors

The National Comprehensive Cancer Network (NCCN) is a nonprofit alliance of 27 leading cancer centers devoted to patient care, research, and education, and is dedicated to improving the quality, effectiveness, and...

The...

04/17/2018

Journal of Clinical Pathways

Society of Gynecological Oncology Annual Meeting on Women`s Cancer

04/17/2018

JCP Editors

The premier medical specialty society for health care professionals trained in the comprehensive management of gynecologic cancers, the Society of Gynecological Oncology (SGO) contributes to the advancement of...

The...

04/17/2018

Journal of Clinical Pathways

Department

Research in Review

04/17/2018

JCP Editors

Texas Oncology, Aetna Collaborate to Improve Patient Care Through Clinical Pathways Texas Oncology and Aetna partnered to provide a practice-based program that reduced costs while maintaining adherence to treatment...

Texas...

04/17/2018

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Editorial Correspondence

April 2018

Column

Feature

Insights

Department

Current Issue

Special Reports

Subscribe

Volume 4

Specialties

Events

Year Round Education

HMP Global Products